Last updated: August 8, 2025
Introduction
Lidocaine Hydrochloride 0.2% combined with Dextrose 5% in a plastic container represents a common formulation used for local anesthesia, primarily in clinical settings. These solutions are critical in pain management, surgical procedures, and diagnostic interventions. The procurement of high-quality, regulatory-compliant supplies from reliable manufacturers is paramount for healthcare providers and pharmaceutical companies. This article evaluates the leading suppliers globally specializing in this formulation, considering their manufacturing standards, product quality, regulatory approval, and distribution networks.
Market Overview of Lidocaine Hydrochloride 0.2% and Dextrose 5% Solution
The combination of lidocaine and dextrose serves as an effective local anesthetic, especially for subcutaneous or intradermal injections. The integrity and sterility of these solutions are regulated by international authorities like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. Suppliers must adhere to Good Manufacturing Practice (GMP) standards to ensure safety, potency, and stability.
Major Suppliers for Lidocaine Hydrochloride 0.2% and Dextrose 5% in Plastic Containers
1. Baxter International Inc.
Overview: A global leader in injectable and infusion solutions, Baxter offers a broad portfolio of anesthetic and intravenous (IV) products, including lidocaine-dextrose formulations.
Product Specifications: Baxter supplies sterile, single-use plastic containers with Lidocaine Hydrochloride 0.2% and Dextrose 5%, compliant with USP and EP standards, suitable for various clinical applications.
Regulatory Approvals: Their products are approved by the FDA, EMA, and regional regulators worldwide.
Distribution Network: Extensive distribution channels across North America, Europe, Asia-Pacific, and Latin America.
2. Hospira (a Pfizer company)
Overview: Hospira specializes in injectable pharmaceuticals, and its portfolio includes formulations of local anesthetics and infusion solutions.
Product Range: Manufactures Lidocaine Hydrochloride 0.2% solutions in plastic containers, compatible for hospital and outpatient use.
Regulatory Status: Compliant with GMP standards, with approvals from multiple health authorities, including FDA and EMA.
Market Presence: Strong presence in North America and global distribution capabilities.
3. B. Braun Melsungen AG
Overview: A leading manufacturer of infusion therapy products and anesthesia solutions, B. Braun provides lidocaine-based formulations in sterile plastic containers.
Product Attributes: Their formulations are known for rigorous quality controls and stability, suitable for various clinical procedures.
Certifications: Holds GMP, ISO certifications, and approvals from health authorities worldwide.
Distribution: Serves markets in Europe, Asia, and emerging markets through an extensive distribution network.
4. Fresenius Kabi
Overview: Known for infusion solutions, Fresenius Kabi manufactures lidocaine-dextrose solutions in plastic containers, adhering to stringent quality standards.
Product Features: Emphasis on sterile manufacturing processes and regulatory compliance, with formulations tailored for pediatric and adult use.
Regulatory Standing: Approved by respective authorities, with global registration and distribution.
5. Sintetica
Overview: Based in Italy, Sintetica produces local anesthetics, including lidocaine solutions, with a focus on high-potency formulations.
Product Portfolio: Offers pre-filled syringes and bottles in plastic containers with reliable stability data.
Regulations: Complies with European directives and GMP standards.
6. Local and Regional Manufacturers
In addition to the international giants, regional manufacturers in India, China, and South America supply lidocaine and dextrose solutions. Companies like Sun Pharmaceutical Industries Ltd., Hubei Hongsheng Pharmaceutical Co., Ltd., and EMS S.P.A. are notable players:
-
Sun Pharmaceutical Industries Ltd. (India): Produces high-quality anesthetic formulations compliant with Indian and international standards, with export markets across Asia, Africa, and some parts of Europe.
-
Hubei Hongsheng Pharmaceutical Co., Ltd. (China): Supplies sterile lidocaine solutions in plastic containers, focusing on domestic and Asian markets.
-
EMS S.P.A. (Italy): Offers premium anesthetic preparations, including sterile solutions with high purity standards, with distribution in Europe and beyond.
Selection Criteria for Suppliers
Choosing an appropriate supplier involves evaluating several factors:
-
Regulatory Compliance: Suppliers should possess necessary regulatory approvals (FDA, EMA, regional), GMP certificates, and adherence to international quality standards.
-
Product Quality and Stability: Consistent uniformity, sterility assurance, and stability data in plastic containers.
-
Manufacturing Capacity & Scalability: Ability to meet supply demands, especially during surges.
-
Pricing & Contract Terms: Competitive pricing with favorable delivery and payment terms.
-
Distribution & Logistics: Efficient supply chain management to ensure timely deliveries globally.
Emerging Trends and Future Outlook
The demand for sterile, ready-to-use anesthetic solutions continues to grow, driven by expanding healthcare infrastructure and procedural volume globally. Manufacturers investing in advanced aseptic manufacturing, packaging innovations—such as pre-filled syringes—and supply chain resilience are positioned favorably. Additionally, the rising emphasis on regulatory harmonization across markets facilitates easier procurement from trusted international suppliers.
Key Considerations for Buyers
- Verify supplier regulatory compliance and audit history.
- Request detailed Certificates of Analysis (CoA) and stability data.
- Assess supply chain robustness, especially for global procurement.
- Prioritize suppliers with proven track records in sterile manufacturing.
- Ensure product labeling and packaging meet regional regulatory requirements.
Key Takeaways
- Leading global pharmaceutical suppliers of Lidocaine Hydrochloride 0.2% and Dextrose 5% in plastic containers include Baxter, Hospira, B. Braun, Fresenius Kabi, and Sintetica, alongside regional manufacturers.
- Strict adherence to GMP, regulatory approval, and high-quality manufacturing processes are prerequisites for reliable suppliers.
- International companies with extensive distribution networks provide more stable supply options, especially during high demand.
- Regional producers can offer cost-effective alternatives but require thorough regulatory and quality evaluations.
- Strategic procurement should include comprehensive supplier audits, quality assessments, and logistical planning to mitigate supply chain disruptions.
FAQs
1. Are there regional differences in the quality or regulatory standards of lidocaine-dextrose solutions?
Yes. While international suppliers often meet global standards (FDA, EMA), regional manufacturers may adhere to domestic regulations which vary in stringency. Buyers should ensure products meet local and international quality requirements and obtain proper certifications.
2. Can imported lidocaine-dextrose solutions in plastic containers be used legally in hospitals?
Compliance depends on regional regulatory approvals. Products must be registered with local health authorities and labeled according to regional regulations to ensure legal and safe end-use.
3. Do suppliers offer customization or pre-filled options for lidocaine-dextrose formulations?
Many manufacturers provide pre-filled syringes or customized packaging solutions, especially in regions emphasizing patient safety and ease of administration.
4. What are the critical factors in selecting a supplier amidst global supply chain challenges?
Regulatory compliance, manufacturing capacity, inventory reliability, logistic robustness, and after-sales support are crucial. Long-term partnerships often mitigate supply risks.
5. How can buyers verify the authenticity and quality of imported lidocaine-dextrose solutions?
Request Certificates of Analysis, GMP certificates, and perform audits if feasible. Confirm product registration status with relevant authorities and verify batch-specific documentation.
References
[1] U.S. Food and Drug Administration (FDA). Injectable drugs and solutions.
[2] European Medicines Agency (EMA). Guidelines on sterile medicinal products.
[3] Baxter International Inc. Product Catalogs.
[4] Hospira (Pfizer). Product Information Sheets.
[5] B. Braun Medical Solutions. Regulatory Approvals.
[6] Fresenius Kabi Product Portfolio.
[7] Sintetica Product Data Sheets.
[8] Market analysis reports on local anesthetics and infusion solutions.
